Cebranopadol

DB12830InvestigationalSmall molecule

Cebranopadol has been used in trials studying the treatment of Pain, Neoplasms, and Chronic Pain.

Chemical structure of Cebranopadol
Mechanism
Curator reviewed
Formula / weight
C24H27FN2O · 378.491 g/mol (avg)
Code names
GRT6005 · TRN-228

Resolves to

Compound
UNII7GDW9S3GN3CAS863513-91-1ChEMBLCHEMBL2364605PubChem11848225
Structure
InChIKeyCSMVOZKEWSOFER-RQNOJGIXSA-NSMILESCN(C)[C@]1(CC[C@@]2(CC1)OCCC1=C2NC2=CC=C(F)C=C12)C1=CC=CC=C1
Targets
P41146OPRL1P35372OPRM1

What you can answer from here — as of June 15, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
16Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Cebranopadol, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In